Bank of America (BAC)

Statistically, since 1980, companies that have conducted forward stock splits have handily outperformed the benchmark S&P 500 in the 12 months following their split announcement.

As the stablecoin industry grows, the potential opportunities for crypto investors continue to expand.

Chime Financial (NASDAQ:CHYM) co-founder and Chief Executive Officer Chris Britt said the company is seeing resilient consumer activity, stronger product engagement and early traction from newer offerings, even as investors continue to question the outlook for lower- and middle-income consumers. Sp

Berkshire Hathaway's new CEO made big moves in the first quarter.

ServiceNow will be an AI winner, one Wall Street analyst says.

What Happened? Shares of enterprise workflow automation company ServiceNow (NYSE:NOW) jumped 8.9% in the afternoon session after Bank of America reinstated c...

NuScale Power's market cap is now below $5 billion.

As AI demand surges, Bank of America believes investors should ignore the competitive noise and keep buying Taiwan Semi stock.

NVDA stock recently hit record highs, but its upcoming earnings report could be the next major catalyst.

These energy stocks are surging amid skyrocketing power demand and ongoing geopolitical conflicts that have disrupted oil and gas markets.

ServiceNow shares pop as the company announces a partnership with Experian. Here’s why the EXPN team-up is bullish for NOW stock in 2026.

Lennar has underperformed the broader market over the past year, and analysts are moderately pessimistic about the stock’s prospects.

Executives from J.B. Hunt Transport Services (NASDAQ:JBHT) said freight-market conditions are tightening, but they attributed much of the shift to capacity leaving the market rather than a broad-based demand rebound. Speaking at a Bank of America transportation conference, Brad Hicks, executive vic

Ripple is promising, but nuclear stocks could be a better bargain.

With credit conditions potentially worsening in the second half of the year, look for a flight to safety.

Insmed (NASDAQ:INSM) Chair and CEO Will Lewis said the company remains confident in the launch trajectory of BRINSUPRI, despite investor concerns over discontinuation rates that followed the company’s latest update. Speaking at a Bank of America healthcare conference, Lewis said the company intended

Nuclear energy could grow into a $10 trillion industry in the next 25 years. For investors who are bullish on nuclear, these two stocks are absolute buys.

Incyte (NASDAQ:INCY) President and CEO Bill Meury said the company’s post-Jakafi growth profile has become “much clearer” over the past year, pointing to continued growth in its commercial business, late-stage pipeline activity and potential launches across oncology and immunology. Speaking at the

IDEAYA Biosciences (NASDAQ:IDYA) said its lead oncology program remains on track for a regulatory submission after reporting positive top-line data in first-line metastatic melanoma, while also highlighting several pipeline programs during a presentation at the Bank of America Global Healthcare Conf

Integra LifeSciences (NASDAQ:IART) is keeping its core strategy intact following a leadership change that returned Stuart to the roles of chairman and chief executive officer, Chief Financial Officer Lea Knight said during a Bank of America med tech conference discussion hosted by analyst Rei Tan.

Henry Schein (NASDAQ:HSIC) executives said the company is seeing continued momentum in its dental business and remains committed to previously outlined operating improvement targets, while acknowledging softness in medical tied to a weaker respiratory illness season. Speaking at a Bank of America h

GRAIL (NASDAQ:GRAL) said demand for its Galleri multi-cancer early detection test has continued to grow despite recent headlines related to its NHS study, according to comments made by Aaron, who identified himself during the discussion as the company’s CFO, at a Bank of America event. Aaron said t

Shares of Citigroup have risen by more than 60% over the past year, trouncing the performance of many peers.

Gilead Sciences (NASDAQ:GILD) Chief Commercial Officer and Head of Corporate Affairs Johanna Mercier said the company is leaning on its HIV business while continuing to build out oncology and inflammation through recent acquisitions and pipeline development. Speaking at the Bank of America Healthca

GE HealthCare Technologies (NASDAQ:GEHC) executives said the company remains confident in its long-term growth prospects despite a disappointing first quarter that led to a reduction in full-year guidance, citing inflationary cost pressures as the primary near-term challenge. Speaking at a Bank of